Clinical trial
MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With…
NCT00373152 · Masonic Cancer Center, University of Minnesota, Other · Withdrawn
Key facts
| NCT number | NCT00373152 |
|---|---|
| Title | MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer |
| Official title | Breast MRI Assessment of Tumor Viability After Radiofrequency Ablation (RFA) |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | Lumpectomy, dynamic contrast-enhanced magnetic resonance imaging, radiofrequency ablation, gadopentetate dimeglumine |
| Enrollment | 0 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Sep 7, 2006 |
| Last update posted | Dec 5, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: